{"id":28554,"date":"2026-07-06T00:00:00","date_gmt":"2026-07-06T00:00:00","guid":{"rendered":"https:\/\/angelboss.com.br\/2026\/07\/06\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\/"},"modified":"2026-07-06T00:00:00","modified_gmt":"2026-07-06T00:00:00","slug":"333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa","status":"publish","type":"post","link":"http:\/\/angelboss.com.br\/en\/2026\/07\/06\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\/","title":{"rendered":"Orion e Shilpa Medicare expandem parceria para desenvolver e fornecer biossimilar de nivolumabe para a Europa"},"content":{"rendered":"<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA Shilpa Medicare Limited anunciou que sua subsidi\u00e1ria integral, Shilpa Biologicals Private Limited, firmou um acordo de codesenvolvimento e fornecimento com a Orion Corporation para um biossimilar intravenoso (IV) de nivolumabe, um dos medicamentos imunoter\u00e1picos mais utilizados no mundo contra o c\u00e2ncer, com o objetivo de ampliar o acesso dos pacientes na Europa.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nO nivolumabe ajudou a inaugurar a era da imuno-oncologia, transformando o progn\u00f3stico de pacientes com c\u00e2nceres como melanoma e c\u00e2ncer de pulm\u00e3o. \u00c0 medida que o medicamento original se aproxima da perda de exclusividade na Europa, esta parceria visa disponibilizar um biossimilar de nivolumabe de alta qualidade, fabricado de acordo com as Boas Pr\u00e1ticas de Fabrica\u00e7\u00e3o da UE (EU-GMP), para um n\u00famero maior de pacientes, reduzindo o \u00f4nus para o sistema de sa\u00fade. Em 2025, o nivolumabe registrou vendas de aproximadamente <b>US$ 4,1 bilh\u00f5es<\/b> (Fonte: IQVIA\/IMS) na Europa \u2014 o que demonstra a dimens\u00e3o da oportunidade.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nDe acordo com o acordo, a <b>Orion<\/b> deter\u00e1 os direitos exclusivos de registro, comercializa\u00e7\u00e3o, distribui\u00e7\u00e3o e venda do biossimilar de nivolumabe em toda a Europa. A <b>Shilpa Biologicals<\/b> liderar\u00e1 o desenvolvimento do produto e atuar\u00e1 como fabricante e fornecedora comercial exclusiva de longo prazo para a Europa. A Shilpa receber\u00e1 pagamentos por marcos de desenvolvimento e regulat\u00f3rios, al\u00e9m de receita de fornecimento ao longo da parceria.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\n\u201cA expans\u00e3o da nossa parceria com a Orion para a imuno-oncologia \u00e9 um momento decisivo para a Shilpa Biologicals\u201d, afirmou <b>Vishnukant Bhutada<\/b>, diretor-geral da Shilpa Medicare. \u201cIsso reflete a confian\u00e7a que nossos parceiros depositam em nossa qualidade, nossa ci\u00eancia e nossa capacidade de fornecer produtos biol\u00f3gicos complexos em larga escala.\u201d<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\n\u201cEstamos satisfeitos em adicionar mais um produto &agrave; nossa parceria estrat\u00e9gica com a Shilpa\u201d, disse <b>Satu Ahom\u00e4ki<\/b>, vice-presidente executiva de Gen\u00e9ricos e Sa\u00fade do Consumidor da Orion Pharma. \u201cEste acordo fortalece nossas opera\u00e7\u00f5es no segmento hospitalar na Europa Continental e reflete o progresso na implementa\u00e7\u00e3o da estrat\u00e9gia da nossa divis\u00e3o de dar a todos acesso a medicamentos de qualidade a pre\u00e7os acess\u00edveis.\u201d<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><b>Sobre a Shilpa Medicare Limited<\/b><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA Shilpa Medicare, com sede na \u00cdndia, \u00e9 uma empresa farmac\u00eautica e biotecnol\u00f3gica diversificada que desenvolve gen\u00e9ricos complexos, produtos biol\u00f3gicos e APIs (Ingredientes Farmac\u00eauticos Ativos). Atrav\u00e9s da Shilpa Biologicals, opera uma plataforma integrada de produtos biol\u00f3gicos que abrange desenvolvimento, amplia\u00e7\u00e3o de escala e fabrica\u00e7\u00e3o comercial em sua unidade com certifica\u00e7\u00e3o EU-GMP em Dharwad.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><b>Sobre a Orion Corporation<\/b><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA Orion Pharma \u00e9 uma empresa farmac\u00eautica n\u00f3rdica com atua\u00e7\u00e3o global e que promove o bem-estar h\u00e1 mais de cem anos. Desenvolve, fabrica e comercializa produtos farmac\u00eauticos para uso humano e veterin\u00e1rio, al\u00e9m de ingredientes farmac\u00eauticos ativos, com um amplo portf\u00f3lio de medicamentos pr\u00f3prios e gen\u00e9ricos e produtos de sa\u00fade para o consumidor. Suas principais \u00e1reas de P&amp;D s\u00e3o oncologia e dor, com produtos pr\u00f3prios para o tratamento de c\u00e2ncer, doen\u00e7as respirat\u00f3rias e neurol\u00f3gicas, entre outras. Em 2025, as vendas l\u00edquidas totalizaram 1.890 milh\u00f5es de euros, com cerca de 4.000 funcion\u00e1rios em todo o mundo.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nO texto no idioma original deste an\u00fancio \u00e9 a vers\u00e3o oficial autorizada. As tradu\u00e7\u00f5es s\u00e3o fornecidas apenas como uma facilidade e devem se referir ao texto no idioma original, que \u00e9 a \u00fanica vers\u00e3o do texto que tem efeito legal.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260703624919r1&amp;sid=brdno&amp;distro=ftp\"><span class=\"bwct31415\"><\/span><\/p>\n<p id=\"mmgallerylink\" xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><span id=\"mmgallerylink-phrase\">Ver a vers\u00e3o original em businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260703624919\/pt\/\" rel=\"follow\" target=\"_blank\">https:\/\/www.businesswire.com\/news\/home\/20260703624919\/pt\/<\/a><\/span><\/p>\n<p><b>Contato:<\/b><\/p>\n<p>\nMonish Shah\n<\/p>\n<p><a href=\"mailto:mediarelations@vbshilpa.com\" rel=\"follow\" shape=\"rect\">mediarelations@vbshilpa.com<\/a><\/p>\n<p><strong>Fonte: <\/strong><a href='http:\/\/www.businesswire.com\/portal\/site\/home\/' target='_blank'>BUSINESS WIRE<\/a><img src='https:\/\/api.dino.com.br\/v2\/news\/tr\/333577?partnerId=4593' alt=\"\" style=\"border:0px;width:1px;height:1px;\" \/><\/p>","protected":false},"excerpt":{"rendered":"<p>A Shilpa Medicare Limited anunciou que sua subsidi\u00e1ria integral, Shilpa Biologicals Private Limited, firmou um acordo de codesenvolvimento e fornecimento com a Orion Corporation para um biossimilar intravenoso (IV) de nivolumabe, um dos medicamentos imunoter\u00e1picos mais utilizados no mundo contra o c\u00e2ncer, com o objetivo de ampliar o acesso dos pacientes na Europa. O nivolumabe<\/p>","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[315],"tags":[324,352,351],"class_list":["post-28554","post","type-post","status-publish","format-standard","category-noticias-corporativas-dino","tag-negocios","tag-saude-e-bem-estar","tag-sociedade"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Orion e Shilpa Medicare expandem parceria para desenvolver e fornecer biossimilar de nivolumabe para a Europa - Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/angelboss.com.br\/en\/2026\/07\/06\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Orion e Shilpa Medicare expandem parceria para desenvolver e fornecer biossimilar de nivolumabe para a Europa - Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss\" \/>\n<meta property=\"og:description\" content=\"A Shilpa Medicare Limited anunciou que sua subsidi\u00e1ria integral, Shilpa Biologicals Private Limited, firmou um acordo de codesenvolvimento e fornecimento com a Orion Corporation para um biossimilar intravenoso (IV) de nivolumabe, um dos medicamentos imunoter\u00e1picos mais utilizados no mundo contra o c\u00e2ncer, com o objetivo de ampliar o acesso dos pacientes na Europa. O nivolumabe\" \/>\n<meta property=\"og:url\" content=\"https:\/\/angelboss.com.br\/en\/2026\/07\/06\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\/\" \/>\n<meta property=\"og:site_name\" content=\"Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-06T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260703624919r1&amp;sid=brdno&amp;distro=ftp\" \/>\n<meta name=\"author\" content=\"DINO\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DINO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/07\\\/06\\\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/07\\\/06\\\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\\\/\"},\"author\":{\"name\":\"DINO\",\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/en\\\/#\\\/schema\\\/person\\\/b6676b8d991f97199ef2d5b8e5c2d8a5\"},\"headline\":\"Orion e Shilpa Medicare expandem parceria para desenvolver e fornecer biossimilar de nivolumabe para a Europa\",\"datePublished\":\"2026-07-06T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/07\\\/06\\\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\\\/\"},\"wordCount\":621,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/07\\\/06\\\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260703624919r1&amp;sid=brdno&amp;distro=ftp\",\"keywords\":[\"NEG\u00d3CIOS\",\"SA\u00daDE E BEM-ESTAR\",\"SOCIEDADE\"],\"articleSection\":[\"Not\u00edcias Corporativas\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/07\\\/06\\\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/07\\\/06\\\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\\\/\",\"url\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/07\\\/06\\\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\\\/\",\"name\":\"Orion e Shilpa Medicare expandem parceria para desenvolver e fornecer biossimilar de nivolumabe para a Europa - Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/07\\\/06\\\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/07\\\/06\\\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260703624919r1&amp;sid=brdno&amp;distro=ftp\",\"datePublished\":\"2026-07-06T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/07\\\/06\\\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/07\\\/06\\\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/07\\\/06\\\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260703624919r1&amp;sid=brdno&amp;distro=ftp\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260703624919r1&amp;sid=brdno&amp;distro=ftp\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/07\\\/06\\\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/angelboss.com.br\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Orion e Shilpa Medicare expandem parceria para desenvolver e fornecer biossimilar de nivolumabe para a Europa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/angelboss.com.br\\\/en\\\/\",\"name\":\"Portal Masculino de Moda, Beleza, Luxo e Business - Angel Boss\",\"description\":\"O Maior Portal sobre Moda, Luxo, Beleza e Business Masculino do Brasil\",\"publisher\":{\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/en\\\/#organization\"},\"alternateName\":\"Maior Portal e Blog de Beleza Masculina e Luxo\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/angelboss.com.br\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/en\\\/#organization\",\"name\":\"Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss\",\"url\":\"https:\\\/\\\/angelboss.com.br\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/angelboss.com.br\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/WhatsApp-Image-2025-12-11-at-12.54.26.jpeg\",\"contentUrl\":\"https:\\\/\\\/angelboss.com.br\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/WhatsApp-Image-2025-12-11-at-12.54.26.jpeg\",\"width\":1280,\"height\":1280,\"caption\":\"Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss\"},\"image\":{\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/en\\\/#\\\/schema\\\/person\\\/b6676b8d991f97199ef2d5b8e5c2d8a5\",\"name\":\"DINO\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f29568383aedf96da155b6f87103b0e04b1c662f982055cda25086444ab33ff8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f29568383aedf96da155b6f87103b0e04b1c662f982055cda25086444ab33ff8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f29568383aedf96da155b6f87103b0e04b1c662f982055cda25086444ab33ff8?s=96&d=mm&r=g\",\"caption\":\"DINO\"},\"url\":\"http:\\\/\\\/angelboss.com.br\\\/en\\\/author\\\/DINO\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Orion e Shilpa Medicare expandem parceria para desenvolver e fornecer biossimilar de nivolumabe para a Europa - Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/angelboss.com.br\/en\/2026\/07\/06\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\/","og_locale":"en_US","og_type":"article","og_title":"Orion e Shilpa Medicare expandem parceria para desenvolver e fornecer biossimilar de nivolumabe para a Europa - Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss","og_description":"A Shilpa Medicare Limited anunciou que sua subsidi\u00e1ria integral, Shilpa Biologicals Private Limited, firmou um acordo de codesenvolvimento e fornecimento com a Orion Corporation para um biossimilar intravenoso (IV) de nivolumabe, um dos medicamentos imunoter\u00e1picos mais utilizados no mundo contra o c\u00e2ncer, com o objetivo de ampliar o acesso dos pacientes na Europa. O nivolumabe","og_url":"https:\/\/angelboss.com.br\/en\/2026\/07\/06\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\/","og_site_name":"Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss","article_published_time":"2026-07-06T00:00:00+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260703624919r1&amp;sid=brdno&amp;distro=ftp","type":"","width":"","height":""}],"author":"DINO","twitter_card":"summary_large_image","twitter_misc":{"Written by":"DINO","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/angelboss.com.br\/2026\/07\/06\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\/#article","isPartOf":{"@id":"https:\/\/angelboss.com.br\/2026\/07\/06\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\/"},"author":{"name":"DINO","@id":"https:\/\/angelboss.com.br\/en\/#\/schema\/person\/b6676b8d991f97199ef2d5b8e5c2d8a5"},"headline":"Orion e Shilpa Medicare expandem parceria para desenvolver e fornecer biossimilar de nivolumabe para a Europa","datePublished":"2026-07-06T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/angelboss.com.br\/2026\/07\/06\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\/"},"wordCount":621,"commentCount":0,"publisher":{"@id":"https:\/\/angelboss.com.br\/en\/#organization"},"image":{"@id":"https:\/\/angelboss.com.br\/2026\/07\/06\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260703624919r1&amp;sid=brdno&amp;distro=ftp","keywords":["NEG\u00d3CIOS","SA\u00daDE E BEM-ESTAR","SOCIEDADE"],"articleSection":["Not\u00edcias Corporativas"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/angelboss.com.br\/2026\/07\/06\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/angelboss.com.br\/2026\/07\/06\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\/","url":"https:\/\/angelboss.com.br\/2026\/07\/06\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\/","name":"Orion e Shilpa Medicare expandem parceria para desenvolver e fornecer biossimilar de nivolumabe para a Europa - Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss","isPartOf":{"@id":"https:\/\/angelboss.com.br\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/angelboss.com.br\/2026\/07\/06\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\/#primaryimage"},"image":{"@id":"https:\/\/angelboss.com.br\/2026\/07\/06\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260703624919r1&amp;sid=brdno&amp;distro=ftp","datePublished":"2026-07-06T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/angelboss.com.br\/2026\/07\/06\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/angelboss.com.br\/2026\/07\/06\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/angelboss.com.br\/2026\/07\/06\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260703624919r1&amp;sid=brdno&amp;distro=ftp","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260703624919r1&amp;sid=brdno&amp;distro=ftp"},{"@type":"BreadcrumbList","@id":"https:\/\/angelboss.com.br\/2026\/07\/06\/333577-orion-e-shilpa-medicare-expandem-parceria-para-desenvolver-e-fornecer-biossimilar-de-nivolumabe-para-a-europa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/angelboss.com.br\/en\/"},{"@type":"ListItem","position":2,"name":"Orion e Shilpa Medicare expandem parceria para desenvolver e fornecer biossimilar de nivolumabe para a Europa"}]},{"@type":"WebSite","@id":"https:\/\/angelboss.com.br\/en\/#website","url":"https:\/\/angelboss.com.br\/en\/","name":"Portal Masculino de Moda, Beleza, Luxo e Business - Angel Boss","description":"O Maior Portal sobre Moda, Luxo, Beleza e Business Masculino do Brasil","publisher":{"@id":"https:\/\/angelboss.com.br\/en\/#organization"},"alternateName":"Maior Portal e Blog de Beleza Masculina e Luxo","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/angelboss.com.br\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/angelboss.com.br\/en\/#organization","name":"Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss","url":"https:\/\/angelboss.com.br\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/angelboss.com.br\/en\/#\/schema\/logo\/image\/","url":"https:\/\/angelboss.com.br\/wp-content\/uploads\/2025\/12\/WhatsApp-Image-2025-12-11-at-12.54.26.jpeg","contentUrl":"https:\/\/angelboss.com.br\/wp-content\/uploads\/2025\/12\/WhatsApp-Image-2025-12-11-at-12.54.26.jpeg","width":1280,"height":1280,"caption":"Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss"},"image":{"@id":"https:\/\/angelboss.com.br\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/angelboss.com.br\/en\/#\/schema\/person\/b6676b8d991f97199ef2d5b8e5c2d8a5","name":"DINO","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f29568383aedf96da155b6f87103b0e04b1c662f982055cda25086444ab33ff8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f29568383aedf96da155b6f87103b0e04b1c662f982055cda25086444ab33ff8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f29568383aedf96da155b6f87103b0e04b1c662f982055cda25086444ab33ff8?s=96&d=mm&r=g","caption":"DINO"},"url":"http:\/\/angelboss.com.br\/en\/author\/DINO\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"http:\/\/angelboss.com.br\/en\/wp-json\/wp\/v2\/posts\/28554","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/angelboss.com.br\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/angelboss.com.br\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/angelboss.com.br\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"http:\/\/angelboss.com.br\/en\/wp-json\/wp\/v2\/comments?post=28554"}],"version-history":[{"count":0,"href":"http:\/\/angelboss.com.br\/en\/wp-json\/wp\/v2\/posts\/28554\/revisions"}],"wp:attachment":[{"href":"http:\/\/angelboss.com.br\/en\/wp-json\/wp\/v2\/media?parent=28554"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/angelboss.com.br\/en\/wp-json\/wp\/v2\/categories?post=28554"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/angelboss.com.br\/en\/wp-json\/wp\/v2\/tags?post=28554"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}